Medical Condition News

RSS

Math models can be useful tools for study of cancer progression

Using mathematical models, researchers in the Integrated Mathematical Oncology (IMO) program at Moffitt Cancer Center are focusing their research on the interaction between the tumor and its microenvironment and the "selective forces" in that microenvironment that play a role in the growth and evolution of cancer.

3 May 2012

New link between motor action and emotion

The way we use our hands may determine how emotions are organized in our brains, according to a recent study published in PLoS ONE by psychologists Geoffrey Brookshire and Daniel Casasanto of The New School for Social Research in New York.

3 May 2012

Enrollment complete in Hanger’s WalkAide System clinical trial for stroke

Hanger Orthopedic Group, Inc. today announced the completion of enrollment in its pivotal INSTRIDE investigational device exemption (IDE) clinical trial studying the effectiveness of its WalkAide System in the rehabilitation of stroke survivors.

3 May 2012

Study investigates use of stem cells to treat lower-limb peripheral artery disease

Research led by vascular surgeons at Dartmouth-Hitchcock may offer new hope to sufferers of peripheral artery disease, the cause of nearly 60,000 lower-limb amputations annually, through the use of a patient's own stem cells.

3 May 2012

MRA, Sports Authority partner in recognition of May's Skin Cancer Awareness Month

Sports Authority, the nation's premier full-line sporting goods retailer, announced today that it has teamed up with the Melanoma Research Alliance (MRA) in recognition of May's Skin Cancer Awareness Month for the second year in a row.

3 May 2012

EKOS launches two landmark clinical studies on pulmonary embolism

EKOS Corporation today announced the launch of two more landmark clinical studies named SEATTLE I & II, intended to further establish the safety and efficacy of its unique, ultrasound-accelerated thrombolysis in treating patients with life-threatening pulmonary embolism.

3 May 2012

Parental history of psychosis linked with increased risk of epilepsy in offspring

Although the two disorders may seem dissimilar, epilepsy and psychosis are associated. Individuals with epilepsy are more likely to have schizophrenia, and a family history of epilepsy is a risk factor for psychosis. It is not known whether the converse is true, i.e., whether a family history of psychosis is a risk factor for epilepsy.

3 May 2012

Study confirms that COX-2 inhibitors predispose people to cardiovascular disease

After nearly 13 years of study and intense debate, a pair of new papers from the Perelman School of Medicine, at the University of Pennsylvania have confirmed exactly how a once-popular class of anti-inflammatory drugs leads to cardiovascular risk for people taking it.

3 May 2012

FDA clears Angioslide’s new 3X100mm PROTEUS device

Angioslide Ltd. a provider of Embolic Capture Angioplasty solutions, today announced that it has received FDA 510(K) clearance for its new 3X100mm PROTEUS device for treating Peripheral Artery Disease in below the knee (BTK) vasculature.

3 May 2012

Women who spend long hours sitting are at increased risk for diabetes

A new study finds women who spend four to seven hours a day sitting are more likely to show early signs of type 2 diabetes, but researchers have found no such link in men. During National Women's Health Week and beyond, the Academy of Nutrition and Dietetics encourages all women to take steps to increase physical activity and decrease their risk of developing diabetes.

2 May 2012

German BfArM grants Moberg Derma approval to initiate Limtop phase II actinic keratosis trial

The German Federal Institute for Drugs and Medical Devices (BfArM) has granted Moberg Derma approval to initiate a clinical phase II trial for Limtop. The aim is to evaluate the efficacy and safety of three different dose regimens of Limtop in a study involving 96 patients with Actinic Keratosis (AK) on the head or face.

2 May 2012

Optimum blood vitamin D levels to reduce risk of major medical events

In testing older patients' blood vitamin D levels, there's uncertainty about where the dividing line falls between enough and not enough. The threshold amount has become controversial as several scientific societies set different targets.

2 May 2012

It's never too late to take control of diabetes

"You could live a normal life." Those were the words that 15-year-old Steve Edelman kept hearing from the nurses when he was hospitalized following his type 1 diabetes diagnosis in 1970. He wondered why they kept repeating this to him.

2 May 2012

Online assessment tool for stroke

Nearly 800,000 Americans will suffer a stroke this year, yet most people in the U.S. cannot identify stroke warning signs or risk factors. HealthONE Stroke Care hopes to change that during May's National Stroke Awareness Month with the introduction of its new Stroke Risk Profiler, an online assessment tool for adults of all ages

2 May 2012

Grape-derived compound may prevent neurodegenerative disorders involving tau neuropathology

Researchers at Mount Sinai School of Medicine have gained insight into the mechanism by which a pathological brain protein called tau contributes to the progression of Alzheimer's disease (AD) and other neurodegenerative disorders. This finding, published in the most recent issue of the Journal of Biological Chemistry, may provide the basis for future investigations on how to prevent tau from damaging brain circuits involved in cognitive function.

2 May 2012

Biosynthetic polyphenol may improve cognitive function in Alzheimer's disease patients

Mount Sinai School of Medicine researchers have succeeded in developing a biosynthetic polyphenol that improves cognitive function in mice with Alzheimer's disease (AD). The findings, published in a recent issue of the Journal of Neuroscience, provide insight in determining the feasibility of biosynthetic polyphenols as a possible therapy for AD in humans, a progressive neurodegenerative disease for which there is currently no cure.

2 May 2012

Expression of tyrosine kinases may limit effectiveness of agents against sarcomas

To better understand the signaling pathways active in sarcomas, researchers at Moffitt Cancer Center used state-of-the-art mass spectrometry-based proteomics to characterize a family of protein enzymes that act as "on" or "off" switches important in the biology of cancer. The tyrosine kinases they identified, the researchers said, could act as "drivers" for the growth and survival of sarcomas.

2 May 2012

Different genes involved in autism tend to be involved in specific processes in the brain

Autism has a strong genetic basis, but so far efforts to identify the responsible genes have had mixed results. The reason for this is that autism is influenced by many different genes, and different genes are involved in different individuals, making it hard to find the common genetic ground between patients.

2 May 2012

Dixie announces new hemp-based Cannabidiol products without THC

Dixie Elixirs and Edibles, Colorado's premier Tetrahydrocannabinol or THC-infused products company, today announced a new line of products which will break entirely new ground for the company in the category of non-THC-infused product development.

2 May 2012

Lenalidomide and SNS01-T combination effective against multiple myeloma

Senesco Technologies, Inc. announced today that a high level of tumor eradication in a mouse model of human multiple myeloma was achieved with a combination of SNS01-T and lenalidomide.

2 May 2012

Medical Condition News

Math models can be useful tools for study of cancer progression

New link between motor action and emotion

Enrollment complete in Hanger’s WalkAide System clinical trial for stroke

Study investigates use of stem cells to treat lower-limb peripheral artery disease

MRA, Sports Authority partner in recognition of May's Skin Cancer Awareness Month

EKOS launches two landmark clinical studies on pulmonary embolism

Parental history of psychosis linked with increased risk of epilepsy in offspring

Study confirms that COX-2 inhibitors predispose people to cardiovascular disease

FDA clears Angioslide’s new 3X100mm PROTEUS device

Women who spend long hours sitting are at increased risk for diabetes

German BfArM grants Moberg Derma approval to initiate Limtop phase II actinic keratosis trial

Optimum blood vitamin D levels to reduce risk of major medical events

It's never too late to take control of diabetes

Online assessment tool for stroke

Grape-derived compound may prevent neurodegenerative disorders involving tau neuropathology

Biosynthetic polyphenol may improve cognitive function in Alzheimer's disease patients

Expression of tyrosine kinases may limit effectiveness of agents against sarcomas

Different genes involved in autism tend to be involved in specific processes in the brain

Dixie announces new hemp-based Cannabidiol products without THC

Lenalidomide and SNS01-T combination effective against multiple myeloma

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News